[Clinical effectiveness of zidovudine]

[Article in Dutch]

Affiliations

[Article in Dutch]

J W Mulder. Ned Tijdschr Geneeskd. 1995.

. 1995 Feb 4;139(5):211-3.

No abstract available

Similar articles

[Anti-HIV therapy (1987-1994): from nothing to confusion].
Lissen E. Lissen E. Med Clin (Barc). 1995 Apr 1;104(12):463-7. Med Clin (Barc). 1995. PMID: 7739285 Review. Spanish. No abstract available.
Evolution of zidovudine dosing.
Stoukides CA, Cichocki TJ. Stoukides CA, et al. Ann Pharmacother. 1992 Jun;26(6):784-5. Ann Pharmacother. 1992. PMID: 1351766 Review. No abstract available.
[Treatment of HIV infection with zidovudine. The good use of AZT].
Régnier B. Régnier B. Rev Prat. 1991 Sep 1;41(19):1801-4. Rev Prat. 1991. PMID: 1925359 Review. French. No abstract available.
Soluble tumor necrosis factor receptors as surrogate markers for the assessment of zidovudine treatment in asymptomatic HIV-1 infection.
Godfried MH, van der Poll T, Mulder JW, Weverling GJ, Endert E, Lange JM, Sauerwein HP. Godfried MH, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Dec 15;10(5):531-9. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 8548332 Clinical Trial.
A pooled analysis of CD4 response to zidovudine and zalcitabine treatment in patients with AIDS and AIDS-related complex.
Gries JM, Troconiz IF, Verotta D, Jacobson M, Sheiner LB. Gries JM, et al. Clin Pharmacol Ther. 1997 Jan;61(1):70-82. doi: 10.1016/S0009-9236(97)90183-1. Clin Pharmacol Ther. 1997. PMID: 9024175 Clinical Trial.